Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study
Ivan Y. Barenboim, Beny Lafer
Brazilian Journal of Psychiatry 2018 DOI: 10.1590/1516-4446-2017-2380 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Open-label Pilot study Peer reviewed |
|---|---|
| Topics | Depression Esketamine Ketamine |
| Citations | 8 |
Abstract
DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.
Citations in the library
Cited by 3
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression JAMA Psychiatry June 5, 2019
- Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability. The Lancet Psychiatry November 1, 2022
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L’humeur Et De L’anxiété (Canmat) Concernant L’utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur The Canadian Journal of Psychiatry November 11, 2020